This article explores those differences in depth—covering origin, chemistry, pharmacology, effects, and legal status—while ...

Based on peer-reviewed research from leading experts, highly concentrated or semi-synthetic 7-OH products pose significant ...

The U.S. Food and Drug Administration is bringing attention to an unlawful dietary supplement that is turning up in online ...

Between September 2023 and September 2024, the CDC reported a staggering 24% decrease in opioid overdose deaths—the largest ...

The FDA tracks and often takes measures to warn consumers of both Tianpetine and Kratom-based products, like 7-Hydroxymitragynine. Gas stations sell both, despite the FDA’s efforts to deter the ...

Mitragynine and 7-hydroxymitragynine (7OH) are the major alkaloids mediating the biological actions of the psychoactive plant kratom. To investigate the structure–activity relationships of mitragynine ...

A combination of data from the FDA and two independent studies prompted a group of scientists to speak out on conversations surrounding 7-OH and its ...

Experts call for 7-OH regulation, not bans amidst the release of new 7-OH studies that show strong safety profile of 7-OH. The new data slams the door closed on continued efforts by industry ...

OH comes from Kratom leaves. Kratom — in general — is increasingly used for treating chronic pain, according to researchers.

HART member producers of 7-OH adopt GMP standards, third-party testing, and child-resistant packaging to further ensure ...

The U.S. opioid crisis has entered a new phase. With a 24% decline in overdose deaths between September 2023 and 2024 (CDC, 2024), public health leaders are celebrating a tentative victory. But beyond ...

While traditional opioid medications like Oxycodone and Tramadol remain widely prescribed, a growing number of Americans are turning to an alternative compound: 7-hydroxymitragynine—also known simply ...